Keyphrases
Arsenic Trioxide
100%
B-cell Leukemia
100%
Melarsoprol
100%
Epstein-Barr Virus
37%
Bcl-2 Family Proteins
25%
Leukemia Cell Lines
25%
Leukemic Cells
25%
B-CLL
25%
Chronic Lymphocytic Leukemia Cells
25%
Apoptosis
12%
Induced Apoptosis
12%
Protein Expression
12%
Drug Use
12%
Programmed Cell Death
12%
Morphological Characteristics
12%
Concentration-dependent
12%
Promyelocytic
12%
Clinical Effect
12%
Therapeutic Action
12%
Apoptosis Induction
12%
Time-dependent Inhibition
12%
Inorganic Arsenic
12%
Organic Arsenicals
12%
B-cell Lymphoproliferative Disorder
12%
Trypanosomiasis
12%
Dose-response Experiments
12%
Prolymphocytes
12%
Medicine and Dentistry
Arsenic Trioxide
100%
B Cell Leukemia
100%
Melarsoprol
100%
Programmed Cell Death
50%
Cell Line
50%
Epstein Barr Virus
37%
Leukemia Cell Line
25%
B-Cell Chronic Lymphocytic Leukemia
25%
Chronic Lymphocytic Leukemia
25%
Disease
12%
B Cell
12%
Protein Expression
12%
Morphology
12%
Downregulation
12%
Lymphoproliferative Disease
12%
Dose Response
12%
Protein Bcl 2
12%
Organoarsenic Derivative
12%
Trypanosomiasis
12%
JVM-2 Cell Line
12%
Messenger RNA
12%
Pharmacology, Toxicology and Pharmaceutical Science
Arsenite
100%
B Cell Leukemia
100%
Melarsoprol
100%
Arsenous Acid
100%
Epstein-Barr Virus
37%
Chronic Lymphatic Leukemia
25%
Disease
12%
Protein Bcl 2
12%
Programmed Cell Death
12%
Lymphoproliferative Disease
12%
Trypanosomiasis
12%
Arsenical
12%
Messenger RNA
12%